The research published at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022 suggests that colorectal cancer can be managed effectively using the chest imaging method. The researchers suggest that patients with certain clinical characteristics can benefit from using the chest imaging method to locate and diagnose cancer that has spread to the lungs. When cancer tends to move from one organ to the other, such cancer is termed metastatic cancer. Hence, this new finding can greatly help patients suffering from metastatic colorectal cancer.
Colorectal cancer is cancer of the colon and rectum. Based on where it is, the cancer is named colon cancer or rectal cancer. Both cancers have common characteristics and of which they are grouped as colorectal cancer. It is one of the most common cancer, ranking third in the ranking for deaths related to cancer. In 2022, the US alone reported over 150,000 new cases of colorectal cancer. Along with this, the country also reported over 50,000 deaths because of colorectal cancer. Globally, around 1.9 million cases of colorectal cancer are reported every year. Out of these reported cases, around 35% of the patients suffering from colorectal cancer die. Because of this, colorectal cancer has become one of the deadliest cancer and one of the deadliest noncommunicable diseases. Currently, there are over 1.37 million people who are living with colorectal cancer. In the US, the number of cases being reported in adults is increasing exponentially. This is alarming mainly because of the characteristics of colorectal cancer. Almost 50% of the patients suffering from colorectal cancer show metastasis. Early detection of cancer helps in its complete removal using surgery and keeping the patient free of cancer for the rest of their lives. One of the most common areas for colorectal cancer to spread is the lungs. Early detection of the cancerous lumps in the chest can help patients to overcome colorectal cancer.
Mara Antonoff, the co-author of this paper stated that patients diagnosed with colorectal cancer want to know how long they will live and what is the condition of their cancer, but due to the lack of data, physicians and researchers are still unclear about the frequency of chest imaging. She further continued with the statement that by using this study, researchers can develop a strategy to develop a better understanding of the frequency and length of chest imaging. Using this study, the researchers can help physicians to identify the frequency of testing and to decide how long a patient should keep under screening for metastasis.
Colorectal cancer has shown a significant decrease in the number of cases being reported in people above the age of 65. In aged people, cancer is more prominent and more frequent. Hence, frequent screening has resulted in better treatment and survival rates for colorectal cancer. Hence, this technique is being given greater importance to managing colorectal cancer in adults. This is especially essential as more and more adults are being diagnosed with colorectal cancer. Frequent chest imaging can help in management of colorectal cancer
Yash Ranjan10/17/2022
The research published at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022 suggests that colorectal cancer can be managed effectively using the chest imaging method. The researchers suggest that patients with certain clinical characteristics can benefit from using the chest imaging method to locate and diagnose cancer that has spread to the lungs. When cancer tends to move from one organ to the other, such cancer is termed metastatic cancer. Hence, this new finding can greatly help patients suffering from metastatic colorectal cancer.
Colorectal cancer is cancer of the colon and rectum. Based on where it is, the cancer is named colon cancer or rectal cancer. Both cancers have common characteristics and of which they are grouped as colorectal cancer. It is one of the most common cancer, ranking third in the ranking for deaths related to cancer. In 2022, the US alone reported over 150,000 new cases of colorectal cancer. Along with this, the country also reported over 50,000 deaths because of colorectal cancer. Globally, around 1.9 million cases of colorectal cancer are reported every year. Out of these reported cases, around 35% of the patients suffering from colorectal cancer die. Because of this, colorectal cancer has become one of the deadliest cancer and one of the deadliest noncommunicable diseases. Currently, there are over 1.37 million people who are living with colorectal cancer. In the US, the number of cases being reported in adults is increasing exponentially. This is alarming mainly because of the characteristics of colorectal cancer. Almost 50% of the patients suffering from colorectal cancer show metastasis. Early detection of cancer helps in its complete removal using surgery and keeping the patient free of cancer for the rest of their lives. One of the most common areas for colorectal cancer to spread is the lungs. Early detection of the cancerous lumps in the chest can help patients to overcome colorectal cancer.
Mara Antonoff, the co-author of this paper stated that patients diagnosed with colorectal cancer want to know how long they will live and what is the condition of their cancer, but due to the lack of data, physicians and researchers are still unclear about the frequency of chest imaging. She further continued with the statement that by using this study, researchers can develop a strategy to develop a better understanding of the frequency and length of chest imaging. Using this study, the researchers can help physicians to identify the frequency of testing and to decide how long a patient should keep under screening for metastasis.
Colorectal cancer has shown a significant decrease in the number of cases being reported in people above the age of 65. In aged people, cancer is more prominent and more frequent. Hence, frequent screening has resulted in better treatment and survival rates for colorectal cancer. Hence, this technique is being given greater importance to managing colorectal cancer in adults. This is especially essential as more and more adults are being diagnosed with colorectal cancer. 
